v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net loss $ (31,988) $ (22,083)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount and deferred financing costs 259 2,770
Loss on change in fair value of warrant liability (2,469) 1,649
Loss on extinguishment of debt 0 7,952
Impairment of digital assets 21,511 776
Stock-based compensation 1,270 2,438
Other adjustments 284 142
Changes in operating assets and liabilities:    
Accounts receivable 178 237
Inventory (892) 0
Prepaid expenses and other assets (631) (416)
Accounts payable 920 (1,282)
Accrued legal settlement 0 (1,500)
Accrued expenses (386) (3,334)
Lease liability payments (347) (434)
Deferred revenue (2,698) (1,286)
Net cash used in operating activities (14,989) (14,371)
Investing activities    
Acquisition payment (1,125) 0
Purchase of digital assets (923) (1,497)
Capital expenditures (158) 0
Net cash used in investing activities (2,206) (1,497)
Financing activities    
Proceeds from borrowings, net of issuance costs 0 9,981
Payments on borrowings (3,132) (25,095)
Proceeds from exercise of options to purchase common stock 16 70
Proceeds from sales of common stock, net of issuance costs 0 29,670
Net cash (used) provided by financing activities (3,116) 14,626
Effect of exchange rate on cash and restricted cash (121) 16
Net decrease in cash and restricted cash (20,432) (1,226)
Cash and restricted cash at the beginning of the period 23,137 4,031
Cash and restricted cash at the end of the period 2,705 2,805
Supplemental disclosure of cash flow information:    
Interest paid 408 1,287
Income taxes paid 0 0
Supplemental disclosures of non-cash activities:    
Right-of-use assets obtained in exchange for operating lease obligations 1,508 0
Non-cash exchange of digital assets 923 0
Issuance of common stock in connection with acquisition of Lyte Technology, Inc. 1,125 0
Proceeds not received related to sales of common stock 0 867
Issuance of common stock for payment of board of director fees $ 0 $ 66

Source